Special Coatings to Prevent Infections on Medical Devices
Official title: Plasma-initiated Cross-linked Nanocoatings asAnti-infection Agents
Funded at Fairleigh Dickinson University · NIH-11121067 · Data updated 2026-11-12
This research is creating smart, antibiotic-free coatings for medical devices like catheters to stop harmful bacteria from causing infections.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Fairleigh Dickinson University NIH-funded |
| Lab location | 1 site (Teaneck, United States) |
| Project start | July 10, 2023 |
| Project end | June 30, 2028 |
| Funding year | 2025 |
| Award (this year) | $216,694 |
| NIH project number | 5R01AI177531-03 |
| Project ID | NIH-11121067 on NIH RePORTER |
Who could benefit from this research
✓Could help
This research is relevant to anyone who might need a medical device or implant, such as a catheter, in the future.
✕Less likely to help
Patients who do not require medical devices or implants would not directly benefit from this specific technology.
What this research studies
Many people get serious infections from medical devices, especially from bacteria that are resistant to antibiotics and form protective layers called biofilms. We are developing innovative coatings that can be applied to devices like catheters to prevent these infections. These special coatings are designed to sense and target bacteria and biofilms directly, rather than just releasing antibiotics. Our goal is to make medical devices safer and reduce the number of life-threatening infections.
Why it matters
Potential benefit: If successful, these coatings could significantly reduce the risk of dangerous infections associated with medical implants and devices, potentially saving lives.
How similar studies have gone: Preliminary data suggests these new coatings are effective against antibiotic-resistant bacteria on biomaterials, indicating promising early results for this novel approach.
Where this research is happening
-
Fairleigh Dickinson University
Teaneck, United States Active
Researchers
- Principal investigator: Traba, Christian X — Fairleigh Dickinson University
- Study coordinator: Traba, Christian X
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.